Literature DB >> 26222109

Refraction and eye anterior segment parameters in schizophrenic patients.

Tongabay Cumurcu1, Sinem Keser1, Birgul Elbozan Cumurcu2, Abuzer Gunduz1, Sukri Kartalci2.   

Abstract

PURPOSE: To evaluate the difference in terms of refractive errors and anterior segment parameters between schizophrenic patients and healthy volunteers.
METHODS: This study compared 70 patients (48 men) who were diagnosed with schizophrenia with a control group of 60 (35 men) who were similar in terms of age, gender, education, and socioeconomic level. Anterior segment examination was performed using a Scheimflug system. Axial length and lens thickness (LT) were measured using optic biometry. The following tests were administered to the psychiatric patient group: Brief Psychiatric Rating Scale (BPRS), Scale for the Assessment of Negative Symptoms (SANS), and Scale for the Assessment of Positive Symptoms (SAPS).
RESULTS: Mild myopia was detected in both the schizophrenic and control groups, with no statistically significant difference (p>0.005). Corneal volume (CV), anterior chamber volume (ACV), anterior chamber depth (ACD), and central corneal thickness (CCT) values were lower in the schizophrenic group, and there was a statistically significant between-group difference (p=0.026, p=0.014, p=0.048, and p=0.005, respectively). LT was greater in schizophrenics, and the difference was found to be statistically significant (p=0.006). A statistically significant negative correlation was found between SAPS and cylinder values (p=0.008). The axial eye length, cylinder value, pupil diameter, mean keratometric value, and anterior chamber angle revealed no statistically significant difference between the groups (p>0.05).
CONCLUSION: No statistically significant difference was detected in terms of refraction disorders between schizophrenics and the healthy control group, while some differences in anterior chamber parameters were present. These results demonstrate that schizophrenics may exhibit clinical and structural differences in the eye.

Entities:  

Mesh:

Year:  2015        PMID: 26222109     DOI: 10.5935/0004-2749.20150046

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  4 in total

1.  Schizophrenia in Translation: Why the Eye?

Authors:  Steven M Silverstein; Joy J Choi; Kyle M Green; Kristen E Bowles-Johnson; Rajeev S Ramchandran
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

2.  The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial.

Authors:  Dora Koller; Miriam Saiz-Rodríguez; Pablo Zubiaur; Dolores Ochoa; Susana Almenara; Manuel Román; Daniel Romero-Palacián; Alejandro de Miguel-Cáceres; Samuel Martín; Marcos Navares-Gómez; Gina Mejía; Aneta Wojnicz; Francisco Abad-Santos
Journal:  Br J Clin Pharmacol       Date:  2020-04-27       Impact factor: 4.335

Review 3.  Associations between psychosis and visual acuity impairment: A systematic review and meta-analysis.

Authors:  Natalie Shoham; Michelle Eskinazi; Joseph F Hayes; Gemma Lewis; Magnus Theodorsson; Claudia Cooper
Journal:  Acta Psychiatr Scand       Date:  2021-06-15       Impact factor: 7.734

4.  Study on the Correlation Between Iris Characteristics and Schizophrenia.

Authors:  Chunsheng Tian; Li Duan; Chunfeng Fu; Juan He; Jiali Dai; Gang Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-08       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.